Psychopharmacological properties of calcium channel inhibitors.
The previous decade has witnessed a major expansion of knowledge of the role played by voltage-sensitive calcium channels in the function of the central nervous system. Significant progress in the field has been made possible with the broadening use of organic calcium channel inhibitors (CCIs, Ca2+ antagonists), until recently considered almost exclusively as peripherally active antianginal and antiarrhythmic drugs. CCIs, however, do penetrate the blood-brain barrier from the periphery. Autoradiographic studies have established a highly heterogeneous distribution of CCI recognition sites within the brain. The existing evidence suggests that CCIs have marked psychotropic properties. The profile of their central activity is unique and spans a wide range of effects. Nevertheless, question regarding potentially confounding potent peripheral effects of these drugs remain. This paper reviews the psychopharmacology of CCIs, concentrating on preclinical data, but including supportive clinical and biochemical evidence as well. It focuses on these drugs' antidepressant, antidopaminergic (neuroleptic-like), anxiolytic and anticonvulsant effects. CCIs may also modify the reinforcing properties of some addictive drugs.
Department of Psychiatry, University of North Carolina, School of Medicine, Chapel Hill 27599.
O
O
Pucilowski
D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D006801:Humans; D011619:Psychotropic Drugs / Q000494:pharmacology*
D002121:Calcium Channel Blockers; D011619:Psychotropic Drugs